This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
11 May 2012

Antisense Pharma Announces New CEO

Antisense Pharma has announced the appointment of Dr. Philippe Calais as CEO.

The biopharmaceutical company Antisense Pharma has announced the appointment of Dr. Philippe Calais as CEO.

 

The native-born Frenchman has more than two decades of international experience in executive positions in biotech and pharmaceutical companies – including Hofmann La-Roche and ICI Pharmaceuticals – and has successfully guided several medicines from their clinical development to their commercialization.

 

Dr. Calais steps in for interim Chief Executive Officer Dr. Hubert Heinrichs, who led the business on an interim basis in addition to his primary duties as Chief Medical Officer since July of last year. Dr. Calais’ international drug development, business and capital market expertise convinced Antisense Pharma’s shareholders that his appo

Related News